Putting Science to Work

In the News

Aim to get back to around 20% revenue growth in FY18: Syngene

Money Control-28/04/2017. The tie-up with the Canadia Company is a good start for the biologics business...

Discovery Chemistry Discovery Biology Safety Assessment Large Molecule Development Chemical Development Formulation Development Stability Studies Polymer Research Integrated Discovery & Development Clinical Development Services Bioinfomatics Antibody Drug Conjugates Oligonucleotide Synthesis Contact Us

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget